1. Home
  2. ITOS vs FOA Comparison

ITOS vs FOA Comparison

Compare ITOS & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • FOA
  • Stock Information
  • Founded
  • ITOS 2011
  • FOA 2013
  • Country
  • ITOS United States
  • FOA United States
  • Employees
  • ITOS N/A
  • FOA 747
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • FOA Finance Companies
  • Sector
  • ITOS Health Care
  • FOA Finance
  • Exchange
  • ITOS Nasdaq
  • FOA Nasdaq
  • Market Cap
  • ITOS 270.7M
  • FOA 247.0M
  • IPO Year
  • ITOS 2020
  • FOA N/A
  • Fundamental
  • Price
  • ITOS $10.02
  • FOA $21.96
  • Analyst Decision
  • ITOS Hold
  • FOA Buy
  • Analyst Count
  • ITOS 6
  • FOA 2
  • Target Price
  • ITOS $10.60
  • FOA $26.25
  • AVG Volume (30 Days)
  • ITOS 2.6M
  • FOA 86.4K
  • Earning Date
  • ITOS 04-28-2025
  • FOA 05-06-2025
  • Dividend Yield
  • ITOS N/A
  • FOA N/A
  • EPS Growth
  • ITOS N/A
  • FOA N/A
  • EPS
  • ITOS N/A
  • FOA 3.94
  • Revenue
  • ITOS $35,000,000.00
  • FOA $429,184,000.00
  • Revenue This Year
  • ITOS N/A
  • FOA $15.98
  • Revenue Next Year
  • ITOS $31.74
  • FOA $9.04
  • P/E Ratio
  • ITOS N/A
  • FOA $5.47
  • Revenue Growth
  • ITOS 177.89
  • FOA 155.35
  • 52 Week Low
  • ITOS $4.80
  • FOA $4.10
  • 52 Week High
  • ITOS $18.13
  • FOA $32.40
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 73.75
  • FOA 54.46
  • Support Level
  • ITOS $8.30
  • FOA $20.50
  • Resistance Level
  • ITOS $11.35
  • FOA $22.40
  • Average True Range (ATR)
  • ITOS 0.53
  • FOA 1.06
  • MACD
  • ITOS 0.22
  • FOA 0.02
  • Stochastic Oscillator
  • ITOS 71.15
  • FOA 55.09

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About FOA Finance of America Companies Inc.

Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.

Share on Social Networks: